532523:BOM
Biocon Ltd
₹348.50
arrow_downward
-0.14%(-0.50) 1D
Oct 9, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532523...
Open
₹349.00
High
₹350.60
Low
₹343.90
Mkt. cap
569.11B
Avg. vol.
717.54K
Volume
92.21K
Dividend
0.14%
Quarterly dividend
₹0.12
Ex-dividend date
Jul 3, 2026
P/E ratio
103.17
52-wk high
₹447.00
52-wk low
₹337.95
EPS
₹3.38
Shares outstanding
600.00M
No. of employees
16K
Open
₹349.00
High
₹350.60
Low
₹343.90
Mkt. cap
569.11B
Avg. vol.
717.54K
Volume
92.21K
Dividend
0.14%
Quarterly dividend
₹0.12
Ex-dividend date
Jul 3, 2026
P/E ratio
103.17
52-wk high
₹447.00
52-wk low
₹337.95
EPS
₹3.38
Shares outstanding
600.00M
No. of employees
16K
News stories
From web sources and news partners
JournalArta
·
3 hours ago
Stock Market Week Ahead: What to Know
ChartMill
·
1 day ago
Friday's session: top gainers and losers in the dow jones index
The Motley Fool
·
17 hours ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
The Washington Post
·
1 day ago
How major US stock indexes fared Friday 10/9/2026
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16.4K
FoundedNov 29, 1978
HeadquartersBengaluru, Karnataka, India
SectorBiotechnology
Websitebiocon.com